Miriam J Smith,Ludwine M Messiaen,D Gareth Evans
Miriam J Smith
The majority of vestibular schwannomas occur as solitary tumors in otherwise healthy individuals with no family history of vestibular schwannomas, while approximately 5% are associated with the tumor suppressor syndrome, NF2-related schwann...
Cathal John Hannan,Aditya Raghunathan,Jamie J Van Gompel et al.
Cathal John Hannan et al.
Vestibular schwannomas (VS) are WHO Grade 1 tumors arising from the vestibule-cochlear nerve and account for 8% of all intracranial neoplasms. In recent years, there has been a dramatic evolution in how the pathology of these tumors is rega...
Rachel Knappett,Marc Fagelson,Don J McFerran
Rachel Knappett
Tinnitus is the second most common presenting symptom of vestibular schwannoma (VS) after hearing loss. There is conflicting evidence regarding the impact of tinnitus and its contribution to the overall quality of life in VS, and there are ...
Peter Kullar,Måns Magnusson,Fredrik Tjernström
Peter Kullar
Dizziness associated with vestibular schwannomas can be considered a diagnostic feature, a posttreatment challenge, or an issue in patients undergoing a wait-and-scan approach. Regardless of the scenario, dizziness has the potential to sign...
Prevention and rehabilitation of facial palsy in patients with vestibular schwannomas [0.03%]
小脑桥脑角肿瘤患者的面神经保护及功能康复治疗
Simon R M Freeman,Ruben Kannan,Charles Nduka
Simon R M Freeman
The close anatomic position of the facial nerve in proximity to a vestibular schwannoma leads to an inherent risk of damage when managing this tumor. The nerve is particularly at risk from microsurgical tumor resection. A clearly transected...
Simon K W Lloyd,Mathieu Trudel,Scott A Rutherford et al.
Simon K W Lloyd et al.
Hearing loss affects 95% of patients with vestibular schwannoma (VS), either because of the disease or its treatment. In untreated tumors, hearing loss is usually progressive but can be sudden and profound in up to 10%. In neurofibromatosis...
Molecular biology and disease models of vestibular schwannomas: State of the art [0.03%]
前庭神经鞘瘤的分子生物学和疾病模型研究进展
Liyam Laraba,David B Parkinson
Liyam Laraba
Vestibular schwannomas arise either sporadically or as part of the familial condition NF2-related schwannomatosis. Almost all schwannomas arise due to the loss of the NF2 tumor suppressor gene, encoding the Merlin protein, and cause a slow-...
Michael D Cusimano,Kislay Kishore
Michael D Cusimano
Secondary trigeminal neuralgia is an infrequent accompaniment of vestibular schwannoma occurring in
Raghunandhan Kumar,Beverly Cheserem,Mohan Kameswaran
Raghunandhan Kumar
The management protocols for vestibular schwannomas (VS) may differ across the world depending on local health-care policies and resources available. Early diagnosis, appropriate intervention, and follow-up may all vary depending on a multi...
The role of the clinical nurse specialist in managing vestibular schwannoma [0.03%]
临床护士专家在前庭神经鞘瘤管理中的作用
Andrea Wadeson,Juliette Buttimore
Andrea Wadeson
A diagnosis of vestibular schwannoma can have a significant impact on a patient. The effect of living with long-term symptoms and the prospect of treatment can lead to an array of functional and psychologic issues. Access to disease-specifi...